Cohen & Steers, Inc.
CNS · NYSE
Company research
Cohen & Steers, Inc. (NYSE: CNS) is a publicly traded, New York-based asset management holding company founded in 1986 by Martin Cohen and Robert Steers, widely recognized as pioneers in listed real estate investment. The firm specializes in liquid real assets and alternative income strategies, with core expertise in real estate securities (including REITs), listed infrastructure, preferred securities, natural resource equities, and commodities, managing approximately $94 billion in assets under management. Through its subsidiaries, Cohen & Steers serves a broad client base of institutional and individual investors — including pension funds, endowments, and foundations — via institutional separate accounts, open-end mutual funds, closed-end funds, and model-based strategies. Headquartered in New York City and led by CEO Joseph Harvey, the firm operates a global platform with offices in London, Dublin, Hong Kong, Tokyo, and Singapore, and is known for generating some of the highest operating margins in the asset management industry through its differentiated, high-conviction approach to specialized asset classes.
Research reports
Yahoo Finance · July 7, 2026Cohen & Steers (CNS) Gains Momentum, Is The Stock Already Fully Valued?
Momentum-focused valuation piece arguing CNS is about 16.8% overvalued versus a fair value estimate of 68, highlighting strong recent share price and three-year total shareholder returns but warning that premium pricing, institutional outflows, and higher expenses tied to active ETF expansion could challenge the sustainability of current valuation.
StockStory · March 30, 2026Cohen & Steers (CNS) Research Report: Q4 CY2025 UpdateDetailed Q4 CY2025 research note that reviews revenue, margins, EPS trends, ROE and tangible book value growth, concluding that while CNS is a solid, well-run business with exceptional ROE and strong TBVPS growth, its long-term revenue and EPS growth are uninspiring and the current 18.6x forward P/E leaves limited upside, so the stock is best kept on a watchlist rather than bought aggressively.
AInvest (independent Research Platform) · January 25, 2026Cohen & Steers: A Quality Income Play at a Discounted ValuationLong-form, institutionally framed thesis that presents CNS as a quality real-assets income play with 2025 EPS growth, AUM and fee-rate resilience, arguing that the share price decline has created a modest valuation discount versus analyst targets and that improving fundamentals, a sizable unfunded institutional pipeline and dividend growth support an overweight positioning despite sector and real-estate-cycle risks.